Synjardy xr and Lantus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Synjardy xr (empagliflozin; metformin hydrochloride) and Lantus (insulin glargine recombinant). Common drug interactions include alopecia among females and ingrowing nail among males.

The phase IV clinical study analyzes what interactions people have when they take Synjardy xr and Lantus. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Synjardy xr?

Synjardy xr has active ingredients of empagliflozin; metformin hydrochloride. eHealthMe is studying from 564 Synjardy xr users. Check the latest studies of Synjardy xr.

What is Lantus?

Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 191,782 Lantus users. Check the latest studies of Lantus.

On Jul, 20, 2026

16 people who take Synjardy xr and Lantus together, and have interactions are studied.

Synjardy xr and Lantus drug interactions.

What are the common drug interactions of Synjardy Xr and Lantus, by gender? *:

female:

Alopecia (absence of hair from areas of the body)
Blood pressure increased
Dysphonia (speech disorder attributable to a disorder of phonation)
Fatigue (feeling of tiredness)
Diarrhoea
Glossitis (infection of tongue with soreness)
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
Rash
Anxiety
Choking (mechanical obstruction of the flow of air from the environment into the lungs)

male:

Ingrowing nail
Localised infection (infection at the single location)
Multiple allergies (allergy to multiple agents)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Non-small cell lung cancer (type of epithelial lung cancer)
Pericardial effusion (fluid around the heart)
Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
Small cell lung cancer (small cell cancer tumour of lung)
Coronary arterial stent insertion
Dysuria (painful or difficult urination)

What are the common drug interactions of Synjardy Xr and Lantus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Ingrowing nail
Localised infection (infection at the single location)
Nasopharyngitis (inflammation of the nasopharynx)
Seasonal allergy (allergic condition due to certain season)
Sinus congestion (blockage of sinus)
Fatigue (feeling of tiredness)
Arrhythmia (irregular heartbeat)
Cardiac arrest
Cardiac pacemaker replacement
Hypersensitivity

60+:

Alopecia (absence of hair from areas of the body)
Blood pressure increased
Choking (mechanical obstruction of the flow of air from the environment into the lungs)
Depression
Dysphagia (a condition in which swallowing is difficult or painful)
Hair colour changes
Hair disorder
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Penile erythema (redness on penis)
Penile infection

What are the existing conditions these people have? *

Type 2 Diabetes: 5 people, 31.25%
Stress And Anxiety: 2 people, 12.50%
Renal Cell Carcinoma (a kidney cancer): 2 people, 12.50%
Pneumonia: 2 people, 12.50%
Pain: 2 people, 12.50%
Nausea (feeling of having an urge to vomit): 2 people, 12.50%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 12.50%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 2 people, 12.50%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 2 people, 12.50%
Cough: 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Synjardy xr and Lantus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously